Cannara Biotech Inc.

TSXV:LOVE Voorraadrapport

Marktkapitalisatie: CA$60.3m

Cannara Biotech Beheer

Beheer criteriumcontroles 3/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Zohar Krivorot

Algemeen directeur

CA$300.0k

Totale compensatie

Percentage CEO-salaris100.0%
Dienstverband CEO5.8yrs
Eigendom CEOn/a
Management gemiddelde ambtstermijn3.9yrs
Gemiddelde ambtstermijn bestuur5.5yrs

Recente managementupdates

Recent updates

These 4 Measures Indicate That Cannara Biotech (CVE:LOVE) Is Using Debt Extensively

Oct 29
These 4 Measures Indicate That Cannara Biotech (CVE:LOVE) Is Using Debt Extensively

Cannara Biotech Inc.'s (CVE:LOVE) 33% Price Boost Is Out Of Tune With Earnings

Aug 22
Cannara Biotech Inc.'s (CVE:LOVE) 33% Price Boost Is Out Of Tune With Earnings

Cannara Biotech (CVE:LOVE) Shareholders Will Want The ROCE Trajectory To Continue

Aug 21
Cannara Biotech (CVE:LOVE) Shareholders Will Want The ROCE Trajectory To Continue

Does Cannara Biotech (CVE:LOVE) Have A Healthy Balance Sheet?

Jul 14
Does Cannara Biotech (CVE:LOVE) Have A Healthy Balance Sheet?

Cannara Biotech Inc.'s (CVE:LOVE) Prospects Need A Boost To Lift Shares

May 09
Cannara Biotech Inc.'s (CVE:LOVE) Prospects Need A Boost To Lift Shares

Here's Why We Think Cannara Biotech (CVE:LOVE) Might Deserve Your Attention Today

Feb 28
Here's Why We Think Cannara Biotech (CVE:LOVE) Might Deserve Your Attention Today

Investor Optimism Abounds Cannara Biotech Inc. (CVE:LOVE) But Growth Is Lacking

Jan 24
Investor Optimism Abounds Cannara Biotech Inc. (CVE:LOVE) But Growth Is Lacking

Cannara Biotech's (CVE:LOVE) Earnings May Just Be The Starting Point

Dec 18
Cannara Biotech's (CVE:LOVE) Earnings May Just Be The Starting Point

Is Cannara Biotech (CVE:LOVE) A Risky Investment?

Jul 29
Is Cannara Biotech (CVE:LOVE) A Risky Investment?

Cannara Biotech Inc.'s (CVE:LOVE) Business Is Yet to Catch Up With Its Share Price

Apr 10
Cannara Biotech Inc.'s (CVE:LOVE) Business Is Yet to Catch Up With Its Share Price

Here's Why Cannara Biotech (CVE:LOVE) Has A Meaningful Debt Burden

Jan 26
Here's Why Cannara Biotech (CVE:LOVE) Has A Meaningful Debt Burden

Cannara Biotech's (CVE:LOVE) Earnings Aren't As Good As They Appear

Jan 27
Cannara Biotech's (CVE:LOVE) Earnings Aren't As Good As They Appear

Cannara Biotech (CVE:LOVE) Has A Somewhat Strained Balance Sheet

Dec 10
Cannara Biotech (CVE:LOVE) Has A Somewhat Strained Balance Sheet

Here's Why Cannara Biotech (CSE:LOVE) Can Afford Some Debt

Mar 16
Here's Why Cannara Biotech (CSE:LOVE) Can Afford Some Debt

Can You Imagine How Cannara Biotech's (CSE:LOVE) Shareholders Feel About The -6.5% Share Price Increase?

Jan 22
Can You Imagine How Cannara Biotech's (CSE:LOVE) Shareholders Feel About The -6.5% Share Price Increase?

Have Insiders Been Buying Cannara Biotech Inc. (CSE:LOVE) Shares?

Dec 18
Have Insiders Been Buying Cannara Biotech Inc. (CSE:LOVE) Shares?

Analyse CEO-vergoeding

Hoe is Zohar Krivorot's beloning veranderd ten opzichte van Cannara Biotech's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
May 31 2024n/an/a

CA$5m

Feb 29 2024n/an/a

CA$6m

Nov 30 2023n/an/a

CA$9m

Aug 31 2023CA$300kCA$300k

CA$7m

May 31 2023n/an/a

CA$5m

Feb 28 2023n/an/a

CA$3m

Nov 30 2022n/an/a

CA$3m

Aug 31 2022CA$75kCA$75k

CA$2m

May 31 2022n/an/a

CA$884k

Feb 28 2022n/an/a

CA$1m

Nov 30 2021n/an/a

CA$1m

Aug 31 2021n/an/a

-CA$2m

May 31 2021n/an/a

-CA$7m

Feb 28 2021n/an/a

-CA$11m

Nov 30 2020n/an/a

-CA$13m

Aug 31 2020CA$92kCA$92k

-CA$12m

May 31 2020n/an/a

-CA$12m

Feb 29 2020n/an/a

-CA$12m

Nov 30 2019n/an/a

-CA$13m

Aug 31 2019CA$150kCA$150k

-CA$12m

Compensatie versus markt: De totale vergoeding ($USD 214.77K ) Zohar } is ongeveer het gemiddelde voor bedrijven van vergelijkbare omvang in de Canadian markt ($USD 169.25K ).

Compensatie versus inkomsten: De vergoeding van Zohar is het afgelopen jaar met meer dan 20% gestegen.

CEO

Zohar Krivorot (47 yo)

5.8yrs

Tenure

CA$300,000

Compensatie

Mr. Zohar Krivorot serves as Chief Executive Officer of Cannara Biotech Inc. since 2019, Director since December 31, 2018 and is its Founder, Chairman of the Board. He served as President at Cannara Biotec...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Zohar Krivorot
CEO & Chairman5.8yrsCA$300.00kgeen gegevens
Nicholas Sosiak
Chief Financial Officer4yrsCA$240.00k0.031%
CA$ 18.7k
Avi Krivorot
Chief Technology Officerno dataCA$300.00kgeen gegevens
Anthony Manouk
VP of Compliance & GMno dataCA$160.00k0.0049%
CA$ 2.9k
Brian Sherman
General Counsel & VP Legal Affairsno datageen gegevensgeen gegevens
David Abitbol
Vice President of Marketing3.8yrsgeen gegevensgeen gegevens
Scott Carroll
Vice President of Marketing & Salesno datageen gegevens0.0034%
CA$ 2.1k
France Landry
Vice President of Human Resources2yrsgeen gegevensgeen gegevens
Julia Bouvet
Chief of Staffno datageen gegevensgeen gegevens
Etienne Ledoux
Executive Officerno dataCA$300.00kgeen gegevens

3.9yrs

Gemiddelde duur

Ervaren management: Het managementteam van LOVE wordt beschouwd als ervaren (gemiddelde ambtstermijn 3.9 jaar).

Bestuursleden

NaamPositieTenureCompensatieEigendom
Zohar Krivorot
CEO & Chairman5.9yrsCA$300.00kgeen gegevens
Jacob Kay
Independent Director5.5yrsCA$20.00k0.24%
CA$ 146.7k
Donald Olds
Independent Lead Director4yrsCA$32.50k1.34%
CA$ 811.2k
Derek Stern
Independent Director5.9yrsgeen gegevens0.42%
CA$ 251.9k
Mary Durocher
Independent Director4.5yrsCA$17.50kgeen gegevens

5.5yrs

Gemiddelde duur

60.5yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van LOVE wordt beschouwd als ervaren (gemiddelde ambtstermijn 5.5 jaar).